HIV and Menopause: A Systematic Review of the Effects of HIV Infection on Age at Menopause and the Effects of Menopause on Response to Antiretroviral Therapy

Table 2

Studies available through 2012 evaluating response to ART across menopause in HIV-infected women.

Authors; (year)	Study design; (followup)	Menopause status	Number of women (total sample; 𝑛=267)	Percent of total participants who were black/African American or Hispanic/Latina	CD4 cell counts in women after ART			HIV viral loads in women after ART
					Measure	Results	𝑃 value	Measure	Results	𝑃 value
Patterson et al. (2009) [36]	Cohort; (2 years)	Pre; Post	220; 47	61% (black/AA); 17% (Hispanic)	Increase in median CD4 from baseline	260 (11.0%); 273 (12.0%)	0.51	Women achieving <50 copies/mL	75%; 77%	>0.99
								Odds ratio of achieving <50 copies/mL for premenopausal women	0.82; (0.36–1.89)	NS

AA: African American, NS: not significant, Pre: premenopausal, Post: postmenopausal.